2021
A link and a study by independent market researcher on Allomedin.
2021
A link and a study by independent market researcher on Allomedin.
2020
A link and a study by independent market researcher on Allomedin.
2020
A study and a link by independent market researcher on Allomedin.
2020
A research paper by independent medical researcher in Russia about FLIP7 and Entomix.
2019
In 2019 we started to realize the program of preclinical trials of new inhalation drug based on FLIP7 complex. We have done 1st step of pharmaceutical development and have got a little Skolkovo grant for that in amount 225, 000 rubles.
2018
In 2018, Allopharm started to be a Skolkovo resident as Allopharm MSK LLC (organized especially for that purpose and was a 100% daughter of Allopharm). Our project “Medical devices and preparations Development based on natural antimicrobial peptides that prevent the formation of biofilms by microorganisms” was higly rated by experts’ group.
2018
This document describes the FLIP7 project – Development of medical products and preparations based on natural antimicrobial peptides that prevent the formation of biofilms by microorganisms.
A research paper by independent Russian military hospital researchers about FLIP7 and Entimix.
The results of the study, supported by a grant from the Russian Science Foundation (RSF), published in the journal PLOS ONE.
2017
The information about the grant was published in the Gazzetta Russian scientific magazine.
2017
In 2017, the science group of Allopharm (Entomed LLC created by Allopharm especially for this project) was the winner of Best Innovative Projects Competition in the science and higher professional education field. This annual Competition was organized by Committee for Science and Higher Education of Russia. The Allopharm project “Biotechnology of obtaining veterinary drugs and diagnostic reagents based on the insect immune system components” was winner and named as “Best innovative idea in 2017”.
2017
This document is an official EXPERT OPINION given by a renowned expert for appraisals in Russia, Mr. Krzhanovskiy S.N, the Vice President for Grants, Expertise and Tender Activities of the Skolkovo Foundation.
This is the file and the link of the interview with Mr. Mr Krzhanovskiy S.N in newspapers about the grant and the importance of this project: 04c. Recognize the future, Science (117996), interview with Sergey Nikolaevic https://www.kommersant.ru/doc/3833992 — This is his interview where he tells how the Skolkovo experts appriasial the projects.
2016
This is the document of the BIG GRANT given by the Russian Scientific Foundation (a Russian government organization) awarded to Professor Sergey I. to start research and development work on FLIP7 and Allostatin.
2016
In 2016, Allopharm took part in X scientific and practical conference of dermatovenerologists and cosmetologists” St. Petersburg dermatological readings” and presented its Entomix and Allomedin products there.
2011
A study and a link by independent market researcher on Allomedin.
2009
In 2009 our technology was the winner of the innovative projects competition “Russian Innovations” (organized by popular Russian Business Expert Magazine (https://expert.ru/ ). The project “Antiviral and antitumoral new generation agents ” was named as The Best PROJECT in 2009 year.
2007
In 2007, Chernysh S. I. took a part in XXIV scientific-practical conference “Rakhmanov readings”, the theme of the conference “Problems of rehabilitation in dermatovenerology” and was one of the experts and took a part in discussions. Also he presented there his Antitumoral and antiviral peptides. The organizer and founder of the award was the Moscow Medical Academy named after I.M. Sechenov.
2007
From 2004 to 2007, our technology partner Allopharm took part in a competition organized by a popular Russian Business Peterburg Magazine (https://www.dp.ru/) and every year received an award as a fast and growing startup business.
2005
In 2005, Chernysh S. I. took part in the Symposium “New developments in dermatovenerology, andrology, obstetrics and gynecology” and was one of the experts and took a part in discussions. Also he presented there his Antitumoral and antiviral peptides.